Related references
Note: Only part of the references are listed.Accumulation of prelamin A induces premature aging through mTOR overactivation
Xumeng Pan et al.
FASEB JOURNAL (2020)
Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups
Maria B. Cubria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Vulnerability of progeroid smooth muscle cells to biomechanical forces is mediated by MMP13
Patricia R. Pitrez et al.
NATURE COMMUNICATIONS (2020)
Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells
Magda R. Hamczyk et al.
EMBO MOLECULAR MEDICINE (2019)
Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning
Camilla Pellegrini et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome
Magda R. Hamczyk et al.
CIRCULATION (2018)
Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome
Leslie B. Gordon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant
Shun Kageyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2018)
Everolimus rescues multiple cellular defects in laminopathy-patient fibroblasts
Amanda J. DuBose et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
Karim Harhouri et al.
NUCLEUS (2018)
An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
Karim Harhouri et al.
NUCLEUS (2018)
Disrupting the LINC complex in smooth muscle cells reduces aortic disease in a mouse model of Hutchinson-Gilford progeria syndrome
Paul H. Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases
Nard Kubben et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway
Daisuke Kinoshita et al.
ONCOTARGET (2017)
Evidence that S6K1, but not 4E-BP1, mediates skeletal muscle pathology associated with loss of A-type lamins
Chen-Yu Liao et al.
CELL DISCOVERY (2017)
Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders
Camilla Evangelisti et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome
Leslie B. Gordon et al.
CIRCULATION (2016)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins
Camilla Evangelisti et al.
ONCOTARGET (2015)
Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1
Haoyue Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Use of microarray hybrid capture and next-generation sequencing to identify the anatomy of a transgene
Amanda J. DuBose et al.
NUCLEIC ACIDS RESEARCH (2013)
Targeting Protein Prenylation in Progeria
Stephen G. Young et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Increased Mammalian Lifespan and a Segmental and Tissue-Specific Slowing of Aging after Genetic Reduction of mTOR Expression
J. Julie Wu et al.
CELL REPORTS (2013)
Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress
Kwai Wa Cheng et al.
EMBO MOLECULAR MEDICINE (2012)
Mechanisms of Premature Vascular Aging in Children With Hutchinson-Gilford Progeria Syndrome
Marie Gerhard-Herman et al.
HYPERTENSION (2012)
Expression of the Hutchinson-Gilford Progeria Mutation during Osteoblast Development Results in Loss of Osteocytes, Irregular Mineralization, and Poor Biomechanical Properties
Eva Schmidt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome
Leslie B. Gordon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
mTOR signaling in disease
Eva Dazert et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria
V. Cenni et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2011)
Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging
Fernando G. Osorio et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells
Kan Cao et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response
Keng Po Lai et al.
EMBO JOURNAL (2010)
Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
Katrin Duevel et al.
MOLECULAR CELL (2010)
S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell Proliferation
Rachel L. Yamnik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Colin Selman et al.
SCIENCE (2009)
Increased mechanosensitivity and nuclear stiffness in Hutchinson-Gilford progeria cells: effects of farnesyltransferase inhibitors
Valerie L. R. M. Verstraeten et al.
AGING CELL (2008)
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model
Brian C. Capell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance
Frederic Tremblay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hutchinson-Gifford Progeria syndrome: Review of the phenotype
Raoul C. M. Hennekam
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation
Shao H. Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome
R Varga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation
SH Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lamin A truncation in Hutchinson-Gilford progeria
A De Sandre-Giovannoli et al.
SCIENCE (2003)
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
M Eriksson et al.
NATURE (2003)
Share Paper
